Predicting the future is a fool’s errand, obviously, because if there’s one thing we know, it’s that we don’t know anything. But by examining data and patterns, it’s possible to give a rough sketch of how very specific situations will probably play out, and a recent study provides a testicular cancer forecast in numerous nations around the globe for 2018 through 2028.
The cancer forecast covers 24 major markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Norway, Denmark, Switzerland, Russia, Turkey, Saudi Arabia, South Africa, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) and is split into 5 year age cohorts. It’s also split by gender, which seems a little silly because testicular cancer is predominantly found in males for reasons that should be obvious (no insult intended to our gender non-conforming readers, love you).
Obviously knowing is half the battle, so the more you know about cancer the better. However, this is certainly a publication for a more professional audience. It’s targeted to drug manufacturers, medical device suppliers and more. That doesn’t mean there’s not interesting data in here, and it’s gratifying to see the research world taking testicular cancer seriously.
To get access to the entire report, click here.Get your balls in the game! Donate to the Sean Kimerling Foundation to win the battle against testicular cancer.